{
    "info": {
        "nct_id": "NCT03875235",
        "official_title": "A Phase III Randomized, Double-Blind Placebo Controlled, Multi-Regional, International Study of Durvalumab in Combination With Gemcitabine Plus Cisplatin Versus Placebo in Combination With Gemcitabine Plus Cisplatin for Patients With First-Line Advanced Biliary Tract Cancers",
        "inclusion_criteria": "Inclusion\n\n1. Histologically confirmed, unresectable advanced or metastatic biliary tract, including cholangiocarcinoma (intrahepatic or extrahepatic) and gallbladder carcinoma.\n2. Patients with previously untreated disease if unresectable or metastatic at initial diagnosis will be eligible.\n3. Patient with recurrent disease >6 months after curative surgery or >6 months after the completion of adjuvant therapy (chemotherapy and/or radiation) will be eligible.\n4. WHO/ECOG PS of 0 or 1\n\nExclusion\n\n1. History of another primary malignancy\n2. Brain metastases or spinal cord compression\n3. Uncontrolled intercurrent illness\n4. Major surgical procedure within 28 days prior to the first dose of IP.\n5. Prior locoregional therapy such as radioembolization\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 130 Years",
        "exclusion_criteria": "",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "3. Uncontrolled intercurrent illness",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled intercurrent illness",
                    "criterion": "intercurrent illness",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Histologically confirmed, unresectable advanced or metastatic biliary tract, including cholangiocarcinoma (intrahepatic or extrahepatic) and gallbladder carcinoma.",
            "criterions": [
                {
                    "exact_snippets": "Histologically confirmed",
                    "criterion": "diagnosis confirmation method",
                    "requirements": [
                        {
                            "requirement_type": "method",
                            "expected_value": "histology"
                        }
                    ]
                },
                {
                    "exact_snippets": "unresectable advanced or metastatic biliary tract, including cholangiocarcinoma (intrahepatic or extrahepatic) and gallbladder carcinoma",
                    "criterion": "disease type and stage",
                    "requirements": [
                        {
                            "requirement_type": "disease",
                            "expected_value": [
                                "biliary tract cancer",
                                "cholangiocarcinoma",
                                "gallbladder carcinoma"
                            ]
                        },
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "unresectable",
                                "advanced",
                                "metastatic"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Patients with previously untreated disease if unresectable or metastatic at initial diagnosis will be eligible.",
            "criterions": [
                {
                    "exact_snippets": "previously untreated disease",
                    "criterion": "disease treatment status",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "previously untreated"
                        }
                    ]
                },
                {
                    "exact_snippets": "unresectable or metastatic at initial diagnosis",
                    "criterion": "disease status at initial diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": [
                                "unresectable",
                                "metastatic"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. WHO/ECOG PS of 0 or 1",
            "criterions": [
                {
                    "exact_snippets": "WHO/ECOG PS of 0 or 1",
                    "criterion": "WHO/ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": [
                                "0",
                                "1"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. History of another primary malignancy",
            "criterions": [
                {
                    "exact_snippets": "History of another primary malignancy",
                    "criterion": "history of another primary malignancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Brain metastases or spinal cord compression",
            "criterions": [
                {
                    "exact_snippets": "Brain metastases",
                    "criterion": "brain metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "spinal cord compression",
                    "criterion": "spinal cord compression",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Major surgical procedure within 28 days prior to the first dose of IP.",
            "criterions": [
                {
                    "exact_snippets": "Major surgical procedure within 28 days prior to the first dose of IP.",
                    "criterion": "major surgical procedure",
                    "requirements": [
                        {
                            "requirement_type": "time since procedure",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days"
                            }
                        },
                        {
                            "requirement_type": "recency relative to first dose of IP",
                            "expected_value": "prior"
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Prior locoregional therapy such as radioembolization",
            "criterions": [
                {
                    "exact_snippets": "Prior locoregional therapy such as radioembolization",
                    "criterion": "prior locoregional therapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 130 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 130 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 130,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Patient with recurrent disease >6 months after curative surgery or >6 months after the completion of adjuvant therapy (chemotherapy and/or radiation) will be eligible.",
            "criterions": [
                {
                    "exact_snippets": "recurrent disease >6 months after curative surgery",
                    "criterion": "recurrent disease after curative surgery",
                    "requirements": [
                        {
                            "requirement_type": "time since curative surgery",
                            "expected_value": {
                                "operator": ">",
                                "value": 6,
                                "unit": "months"
                            }
                        },
                        {
                            "requirement_type": "recurrence status",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "recurrent disease >6 months after ... completion of adjuvant therapy (chemotherapy and/or radiation)",
                    "criterion": "recurrent disease after adjuvant therapy",
                    "requirements": [
                        {
                            "requirement_type": "time since completion of adjuvant therapy",
                            "expected_value": {
                                "operator": ">",
                                "value": 6,
                                "unit": "months"
                            }
                        },
                        {
                            "requirement_type": "recurrence status",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "Inclusion",
            "criterions": []
        },
        {
            "line": "Exclusion",
            "criterions": []
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}